ornithylaspartate has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Álvares-da-Silva, MR; Behrens, L; Cerski, CT; de Freitas, LBR; de Souza, VEG; Filippi-Chiela, E; Leonhard, LC; Lima, GJSP; Longo, L; Luchese, E; Pereira, MHM; Pinzon, CE; Uribe-Cruz, C; Zanettini, G | 1 |
| Jalan, R; Seery, JP; Taylor-Robinson, SD | 1 |
1 review(s) available for ornithylaspartate and Disease Models, Animal
| Article | Year |
|---|---|
Review article: pathogenesis and treatment of chronic hepatic encephalopathy.
Topics: Animals; Anti-Bacterial Agents; Blood-Brain Barrier; Cerebral Cortex; Diet; Dipeptides; Disaccharides; Disease Models, Animal; Dopamine Agonists; Energy Metabolism; GABA Agents; Hepatic Encephalopathy; Humans; In Vitro Techniques; Intestinal Absorption; Neurotoxins; Synaptic Transmission; Tomography, Emission-Computed | 1996 |
1 other study(ies) available for ornithylaspartate and Disease Models, Animal
| Article | Year |
|---|---|
Ornithine Aspartate and Vitamin-E Combination Has Beneficial Effects on Cardiovascular Risk Factors in an Animal Model of Nonalcoholic Fatty Liver Disease in Rats.
Topics: Animals; Cardiovascular Diseases; Dipeptides; Disease Models, Animal; Drug Therapy, Combination; Liver; MicroRNAs; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Risk Factors; Vitamin E | 2022 |